Related Experiment Video

Updated: May 9, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Paediatrics: Children need optimal management of chronic hepatitis B

Mei-Hwei Chang1

  • 1Department of Paediatrics and Hepatitis Research Centre, National Taiwan University Hospital, 8 Chung-Shan South Road, Taipei, Taiwan. changmh@ntu.edu.tw.

Nature Reviews. Gastroenterology & Hepatology
|July 31, 2013
PubMed

Insights

Current chronic Hepatitis B virus (HBV) therapies target adults, but childhood HBV infection is common. Early pediatric treatment is crucial for long-term health and preventing complications.

Area of Science:

  • Hepatology
  • Pediatric Infectious Diseases
  • Virology

Background:

  • Chronic Hepatitis B virus (HBV) infection predominantly affects adults, with current therapeutic strategies primarily designed for this demographic.
  • HBV infection frequently occurs during infancy or childhood, especially in regions where the virus is endemic.
  • Pediatric HBV infection poses a significant long-term health burden due to the prolonged lifespan of affected children.

Discussion:

  • The lack of pediatric-specific HBV treatment guidelines necessitates a re-evaluation of therapeutic approaches.
  • Early intervention in childhood HBV infection is critical to mitigate the risk of developing severe complications such as cirrhosis and hepatocellular carcinoma.
  • Addressing the unique physiological and immunological aspects of pediatric HBV infection is essential for effective management.

Key Insights:

  • Pediatric chronic HBV infection is a critical unmet medical need, distinct from adult disease.
  • Timely and appropriate treatment in children can prevent irreversible liver damage and long-term sequelae.
  • Current adult-focused therapies may not be optimal for the pediatric population, highlighting a gap in care.

Outlook:

  • Future research should focus on developing and validating safe and effective antiviral therapies for pediatric HBV infection.
  • Establishing pediatric-specific HBV treatment protocols is essential for improving long-term outcomes.
  • International collaboration is needed to address the global burden of childhood HBV infection and ensure equitable access to care.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...